Open Now
Contact Information
1035 Porter Pike , Bowling Green, Kentucky 42103, United States
Detailed Information
Rivendell Behavioral Health Services
-
Services:
- Methamphetamines detoxification
- Alcohol Detoxification
- Benzodiazepines Detoxification
- Medication routinely used during detoxification
- Opioids detoxification
- Cocaine Detoxification
- Sign language services for the deaf and hard of hearing
- Hepatitis B (HBV) vaccination
- Psychiatric hospital
- This facility administers/prescribes medication for alcohol use disorder
- TB screening
- HIV testing
- Drug or alcohol urine screening
- Testing for Hepatitis C (HCV)
- Metabolic syndrome monitoring
- STD testing
- Testing for Hepatitis B (HBV)
- Breathalyzer or blood alcohol testing
- Children/Adolescents
- Housing services
- Self-help groups
- Assistance with obtaining social services
- Clients with co-occurring mental and substance use disorders
- Adult men
- Adolescents
- Adult women
- Young adults
- Vaping not permitted
- Other contracted prescribing entity
- Private for-profit organization
- Outpatient day treatment or partial hospitalization
- Hospital inpatient detoxification
- Hospital inpatient/24-hour hospital inpatient
- Regular outpatient treatment
- Outpatient
- Outpatient methadone/buprenorphine or naltrexone treatment
- Intensive outpatient treatment
- Hospital inpatient treatment
- Smoking permitted in designated area
- HIV or AIDS education, counseling, or support
- Smoking/vaping/tobacco cessation counseling
- Hepatitis education, counseling, or support
- Substance use disorder education
- Health education services other than HIV/AIDS or hepatitis
- Family counseling
- Group counseling
- Individual counseling
- Aftercare/continuing care
- Naloxone and overdose education
- Discharge Planning
- Case management service
- Social skills development
- Suicide prevention services
- Mental health services
- Acamprosate (CampralĀ®)
- Disulfiram
- Naltrexone (oral)
- Nicotine replacement
- Non-nicotine smoking/tobacco cessation
- Medication for mental disorders
- Clonidine
- Naltrexone (extended-release, injectable)
- Buprenorphine without naloxone
- Buprenorphine with naloxone
- Buprenorphine (extended-release, injectable)
- Male
- Female
- Screening for tobacco use
- Outreach to persons in the community
- Comprehensive mental health assessment
- Comprehensive substance use assessment
- Screening for mental disorders
- Screening for substance use
- Interim services for clients
- Complete medical history/physical exam
- Other contracted prescribing entity
- In-network prescribing entity
- Private health insurance
- IHS/Tribal/Urban (ITU) funds
- Medicare
- State-financed health insurance plan other than Medicaid
- Federal military insurance (e.g., TRICARE)
- Medicaid
- Cash or self-payment
- The Joint Commission
- Hospital licensing authority
- Naltrexone used in Treatment
- Buprenorphine used in Treatment
- Buprenorphine detoxification
- Accepts clients using MAT but prescribed elsewhere
- Maintenance service with medically supervised withdrawal after stabilization
- Prescribes buprenorphine
- Prescribes naltrexone
- Substance use treatment
- Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children
- Detoxification
- Motivational interviewing
- Cognitive behavioral therapy
- Anger management
- 12-step facilitation
- Telemedicine/telehealth therapy
- Relapse prevention
- Trauma-related counseling
- Brief intervention
- Substance use disorder counseling
- Contingency management/motivational incentives
Detoxification (medical withdrawal) Services
Language Services
Medical Services
Hospitals
Type of Alcohol Use Disorder Treatment
Testing
Age Groups Accepted
Recovery Support Services
Special Programs/Groups Offered
Facility Vaping Policy
External Opioid Medications Source
Facility Operation (e.g., Private, Public)
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Facility Smoking Policy
Education and Counseling Services
Transitional Services
Ancillary Services
Pharmacotherapies
Gender Accepted
Assessment/Pre-treatment
External Source of Medications Used for Alcohol Use Disorder Treatment
Payment/Insurance/Funding Accepted
License/Certification/Accreditation
Opioid Medications used in Treatment
Type of Opioid Treatment
Type of Care
Treatment Approaches
Opening Hours
Monday
6:00 am - 10:00 pm
Tuesday
6:00 am - 10:00 pm
Wednesday
6:00 am - 10:00 pm
Thursday
6:00 am - 10:00 pm
Friday
6:00 am - 10:00 pm
Saturday
6:00 am - 10:00 pm
Sunday
6:00 am - 10:00 pm